Search research articles
Contact Us
Filters
Showing results (51-60 of 99) with videos related to
Page
of 10
Sort By:
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
March 27, 2007
Hybrid titania-aminosilane platforms evaluated with human mesenchymal stem cells
M Manso-Silván, C Rodríguez-Navas, M Arroyo-Hernández, et al.
Cancer
|
September 5, 2002
Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine
Joaquim Bellmunt, Joan Albanell, Luis Paz-Ares, et al.
European Urology
|
February 3, 2012
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial
Camillo Porta, Emiliano Calvo, Miguel A Climent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2022
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
J Oldenburg, D M Berney, C Bokemeyer, et al.
Revista Clinica Espanola
|
April 1, 1993
[The clinico-mammographic follow-up of breast cancer after conservative treatment]
M A Climent Durán, A Gómez Gómez, M A Seguí Palmer, et al.
Journal of Clinical Medicine
|
February 15, 2022
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy
Juan Carlos Pardo, Tamara Sanhueza, Vicenç Ruiz de Porras, et al.
Critical Reviews in Oncology/Hematology
|
January 31, 2012
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer
Miguel A Climent, Josep María Piulats, Alfredo Sánchez-Hernández, et al.
Anticancer Research
|
May 15, 1998
p53 oncoprotein as a prognostic indicator in patients with breast cancer
R Molina, M A Segui, M A Climent, et al.
Actas Urologicas Espanolas
|
July 22, 2004
[Usefulness of serum markers in renal cell carcinoma]
J Rubio Briones, I Iborra Juan, E Aznar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
J Tabernero, M A Climent, A Lluch, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 99) with videos related to
Sort By:
Page
of 10
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
March 27, 2007
Hybrid titania-aminosilane platforms evaluated with human mesenchymal stem cells
M Manso-Silván, C Rodríguez-Navas, M Arroyo-Hernández, et al.
Cancer
|
September 5, 2002
Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine
Joaquim Bellmunt, Joan Albanell, Luis Paz-Ares, et al.
European Urology
|
February 3, 2012
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial
Camillo Porta, Emiliano Calvo, Miguel A Climent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2022
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
J Oldenburg, D M Berney, C Bokemeyer, et al.
Revista Clinica Espanola
|
April 1, 1993
[The clinico-mammographic follow-up of breast cancer after conservative treatment]
M A Climent Durán, A Gómez Gómez, M A Seguí Palmer, et al.
Journal of Clinical Medicine
|
February 15, 2022
Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy
Juan Carlos Pardo, Tamara Sanhueza, Vicenç Ruiz de Porras, et al.
Critical Reviews in Oncology/Hematology
|
January 31, 2012
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer
Miguel A Climent, Josep María Piulats, Alfredo Sánchez-Hernández, et al.
Anticancer Research
|
May 15, 1998
p53 oncoprotein as a prognostic indicator in patients with breast cancer
R Molina, M A Segui, M A Climent, et al.
Actas Urologicas Espanolas
|
July 22, 2004
[Usefulness of serum markers in renal cell carcinoma]
J Rubio Briones, I Iborra Juan, E Aznar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2004
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
J Tabernero, M A Climent, A Lluch, et al.
Page
of 10